Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.72 - $4.99 $13,425 - $24,630
-4,936 Reduced 26.1%
13,978 $43,000
Q1 2024

May 15, 2024

SELL
$2.88 - $6.8 $12,902 - $30,464
-4,480 Reduced 19.15%
18,914 $98,000
Q4 2023

Feb 14, 2024

BUY
$1.73 - $3.39 $14,962 - $29,320
8,649 Added 58.66%
23,394 $75,000
Q3 2023

Nov 14, 2023

BUY
$2.55 - $5.65 $37,599 - $83,309
14,745 New
14,745 $37,000

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $60.4M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.